EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic Cancer
Status:
Terminated
Trial end date:
2019-06-14
Target enrollment:
Participant gender:
Summary
The goal of this project is to determine if EUS-CPN without Bupivacaine (versus EUS-CPN with
Bupivacaine) can reduce pain scores and improve quality of life in patients with inoperable
pancreatic cancer by reducing the morbidity due to narcotic side effects (e.g. nausea,
excessive sedation, constipation).